Showing results (1-10 of 165) with videos related to
Sort By:
Pageof 17
Pharmaceutical Research|April 1, 1999
Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: concepts and perspectivesH Derendorf, B MeibohmInternational Journal of Clinical Pharmacology and Therapeutics|November 14, 1997
Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modellingB Meibohm, H DerendorfInternational Journal of Clinical Pharmacology and Therapeutics|December 10, 1999
Gender differences in pharmacokinetics and pharmacodynamicsI Beierle, B Meibohm, H DerendorfThe Journal of Allergy and Clinical Immunology|May 1, 1998
Pharmacokinetics and pharmacodynamics of inhaled corticosteroidsH Derendorf, G Hochhaus, B Meibohm, et al.International Journal of Clinical Pharmacology and Therapeutics|November 14, 1997
Clinical PK/PD modelling as a tool in drug development of corticosteroidsH Derendorf, H Möllmann, G Hochhaus, et al.Die Pharmazie|April 11, 2000
Optimized therapeutic ratio of inhaled corticosteroids using retrometabolismH Derendorf, G Hochhaus, S Krishnaswami, et al.Journal of Clinical Pharmacology|October 1, 1996
Dynamic modeling of cortisol reduction after inhaled administration of fluticasone propionateS Rohatagi, A Bye, C Falcoz, et al.Journal of Pharmacokinetics and Biopharmaceutics|November 24, 1999
A pharmacokinetic/pharmacodynamic approach to predict the cumulative cortisol suppression of inhaled corticosteroidsB Meibohm, G Hochhaus, H Möllmann, et al.International Journal of Clinical Pharmacology and Therapeutics|September 4, 1999
Mechanism-based PK/PD model for the lymphocytopenia induced by endogenous and exogenous corticosteroidsB Meibohm, H Derendorf, H Möllmann, et al.Journal of Clinical Pharmacology|August 1, 1997
Dependency of cortisol suppression on the administration time of inhaled corticosteroidsB Meibohm, G Hochhaus, S Rohatagi, et al.Pageof 17